Determination of myocardial viability with ECG-gated fluorodeoxyglucose F-18 positron emission tomography

Clinical Positron Imaging (Netherlands)

Volumn 2, Issue 4, 1999, Pages 183-190

  Bom, Hee Seung ^a,b   Vansant, John P ^a,c   Pettigrew, Roderic I ^a   Cooke, C David ^a   Votaw, John R ^a   Garcia, Ernest V ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Chonnam National University   (South Korea)

^c EMORY UNIVERSITY HOSPITAL   (United States)

Author keywords

Gated Fluorodeoxyglucose F 18 (FDG); Myocardial viability; Positron Emission Tomography (PET)

Indexed keywords

EID: 2942640929     PISSN: 10950397     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1095-0397(99)00021-7     Document Type: Article

References (15)

1. R.C. Marshall J.H. Tillisch M.E. Phelps Identification and differentiation of resting myocardial ischemia and infarction in man with positron computed tomography, F-18 labeled fluorodeoxyglucose and N-13 ammonia Circulation 67 1983 766 778
2. J. Tillisch R. Brunken R. Marshall Reversibility of cardiac wall-motion abnormalities predicted by positron tomography N. Engl. J. Med. 314 1986 884 888
3. N. Tamaki Y. Yonekura K. Yamashita Positron emission tomography using fluorine-18 deoxyglucose in evaluation of coronary artery bypass grafting Am. J. Cardiol. 64 1989 860 865
4. J. vom Dahl D.T. Eitzman Z.R. Al-Aouar Relation of regional function, perfusion, and metabolism in patients with advanced coronary artery disease undergoing surgical revascularization Circulation 90 1994 2356 2366
5. M.J. Knuuti M. Saraste P. Nuutila Myocardial viability Fluorine-18-deoxyglucose positron emission tomography in prediction of wall motion recovery after revascularization Am. Heart J. 127 1994 785 796
6. E.V. Garcia J.P. Vansant Assessment of mechanical function as an adjunct to myocardial perfusion/metabolism emission tomography studies J. Nucl. Med. 35 1994 1005 1006
7. K. Yamashita N. Tamaki Y. Yonekura Quantitative analysis of regional wall motion by gated myocardial positron emission tomography validation and comparison with left ventriculography J. Nucl. Med. 30 1989 1775 1786
8. W. Mueller-Schauenburg H.M. Hoffmeister U. Helber R. Lietzenmayer U. Feine Gated cardiac FDG PET improved by Fourier analysis in comparison with cineventriculography (abstract) J. Nucl. Med. 36 1995 141P
9. Cooke, C.D.; Garcia, E.V.; Folks, R.D.; Perfer, J.W.; Ezquerra, N.F. Visualization of cardiovascular nuclear medicine tomographic perfusion studies. Proceedings of the First Conference on Visualization in Biomedical Computing. Atlanta: IEEE Catalog Number 90TH0311-1, 1990: 185–9.
10. P. Perrone-Filardi S.L. Bacharach V. Dilsizian S. Maurea J.A. Frank R.O. Bonow Regional left ventricular wall thickening. Relation to regional uptake of 18fluorodeoxyglucose and 201T1 in patients with chronic coronary artery disease and left ventricular dysfunction Circulation 86 1992 1125 1137
11. R.O. Bonow V. Dilsizian A. Cuocolo S.L. Bacharach Identification of viable myocardium in patients with chronic coronary artery disease and left ventricular dysfunction comparison of thallium scintigraphy with reinjection and PET imaging with 18F-fluorodeoxyglucose Circulation 83 1991 26 37
12. C. Altehoefer H.J. Kaiser R. Doerr Fluorine-18 deoxyglucose PET for assessment of viable myocardium in perfusion defects in Tc-99m MIBI SPECT a comparative study in patients with coronary artery disease Eur. J. Nucl. Med. 19 1992 334 342
13. M.J. Knuuti P. Nuutila U. Ruotsalainen The value of quantitative analysis of glucose utilization in detection of myocardial viability by PET J. Nucl. Med. 34 1993 2068 2075
14. J. Czernin G. Porenta R. Brunken Regional blood flow, oxidative metabolism, and glucose utilization in patients with recent myocardial infarction Circulation 88 1993 884 895
15. W. Picker S. Nekolla S. Ziegler M. Schwaiger Evaluation of quantitative criteria for definition of cardiac tissue viability by PET using automated analysis (abstract) J. Nucl. Med. 36 1995 140P